Seven Eight Capital, LP Penumbra Inc Transaction History

Seven Eight Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$220.09 - $273.15 $670,394 - $832,014	3,046 New	3,046 $679,000
Q3 2018 Oct 18, 2018	SELL	$121.55 - $156.8 $1.3 Million - $1.68 Million	-10,700 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$112.2 - $165.95 $1.05 Million - $1.56 Million	-9,400 Reduced 46.77%	10,700 $1.48 Million
Q1 2018 May 14, 2018	BUY	$84.6 - $126.1 $1.7 Million - $2.53 Million	20,100 New	20,100 $2.33 Million

473

30.6M

309K

95.9K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.6B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.